211 related articles for article (PubMed ID: 2898382)
1. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
[TBL] [Abstract][Full Text] [Related]
2. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
Schiaffella F; Fringuelli R; Cecchetti V; Fravolini A; Angeli P; Marucci G
Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
[TBL] [Abstract][Full Text] [Related]
4. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of certain 3-[4-[2-hydroxy-3-(isopropylamino) propoxy]phenyl]propionate as beta-adrenergic blocking agents.
Ahmed AN
J Pharm Belg; 1987; 42(6):389-94. PubMed ID: 2895806
[No Abstract] [Full Text] [Related]
7. [Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity].
Gesquière JC; Dhaisne JM; Marcinal-Lefebvre A; Bar D; Vincent A; Dupuis B
Ann Pharm Fr; 1982 Sep; 40(3):251-7. PubMed ID: 6129826
[No Abstract] [Full Text] [Related]
8. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
[TBL] [Abstract][Full Text] [Related]
9. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols.
Large MS; Smith LH
J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155
[TBL] [Abstract][Full Text] [Related]
10. Bivalent ligand type beta-adrenolytics related to practolol.
Rampa A; Da Re P; Valenti P; Frigeni V; Sala R; Della Bella D
Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
[TBL] [Abstract][Full Text] [Related]
12. [Adrenergic beta 1 and beta 2 blocking activity of new aminopropanols derived from oximes and esters].
Rosell G; Mauleón D; Granados R; Selva C
Arch Farmacol Toxicol; 1984 Aug; 10(2):101-6. PubMed ID: 6151379
[No Abstract] [Full Text] [Related]
13. Syntheses of the optical isomers of befunolol.HCl and their beta-adrenergic blocking activities.
Nakano J; Mimura M; Hayashida M; Fujii M; Kimura K; Nakanishi T
Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1399-403. PubMed ID: 2901296
[No Abstract] [Full Text] [Related]
14. Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.
Amlaiky N; Leclerc G
J Pharm Sci; 1985 Oct; 74(10):1117-9. PubMed ID: 2867200
[TBL] [Abstract][Full Text] [Related]
15. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis of 2-{3-[4-(4-fluorophenyl)-1-piperazinyl]-2-hydroxy-propoxy}-phenylcarbamic acid alkylesters and in vitro evaluation of their beta-antiadrenergic and vasodilatative activities].
Gonec T; Racanská E; Csöllei J
Ceska Slov Farm; 2008 Jun; 57(3):115-8. PubMed ID: 18683428
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
[TBL] [Abstract][Full Text] [Related]
18. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacodynamics of carteolol].
Odenthal KP
Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
